News Daily News Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER Michael O'Riordan December 12, 2025
News Daily News Making Sense of Masters Athletes’ Cardiac Imaging: Expert Review Michael O'Riordan December 11, 2025
News Daily News Frail Patients Stand to Gain Most From Cardiac Rehab Michael O'Riordan November 26, 2025
News Daily News Risk Calculators Miss Many Patients Who Present With First MI Michael O'Riordan November 21, 2025
News Daily News High Adolescent BP Tied to Subclinical Disease in Middle Age Michael O'Riordan November 20, 2025
News Conference News AHA 2025 Lower Mortality With Complete Revascularization in Acute MI Patients With MVD Michael O'Riordan November 12, 2025
News Conference News AHA 2025 CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI Michael O'Riordan November 11, 2025
News Conference News TCT 2025 INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time Michael O'Riordan October 29, 2025
News Conference News TCT 2025 STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus Michael O'Riordan October 28, 2025
News Conference News TCT 2025 Concerto in the Cath Lab: Music Benefits Heart Health After PCI Michael O'Riordan October 25, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Daily News Risk Factors Present in Nearly All Patients Who Develop CVD Michael O'Riordan October 02, 2025
News Daily News CVD Still the Leading Cause of Death and Disease Globally Michael O'Riordan September 24, 2025
News Daily News CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI Michael O'Riordan September 23, 2025
News Daily News Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s Michael O'Riordan September 18, 2025
News Conference News ESC 2025 ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients Michael O'Riordan September 10, 2025
News Conference News ESC 2025 No Benefit to Routine CT Angiography After Left Main PCI: PULSE Michael O'Riordan August 31, 2025
News Conference News ESC 2025 Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF Michael O'Riordan August 30, 2025
News Daily News Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT Michael O'Riordan July 31, 2025
News Daily News No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits Michael O'Riordan July 14, 2025